Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 7/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.44 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.44 |
| ▸ | APLNR | P35414 | 1/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2946942 | 1.00 | OPRM1 (0.44) | OPRM1OPRK1F2NTSR2NTSR1 | |
| SCHEMBL30487567 | 0.91 | NTSR2 (0.47) | OPRM1OPRK1F2NTSR2NTSR1 | |
| SCHEMBL30120960 | 0.88 | OPRM1 (0.47) | OPRM1OPRK1APLNR | |
| SCHEMBL30173956 | 0.87 | APLNR (0.43) | OPRM1OPRK1APLNR | |
| SCHEMBL30676238 | 0.86 | EPHA2 (0.46) | OPRM1OPRK1NTSR2NTSR1SORT1 | |
| SCHEMBL31099288 | 0.86 | F2 (0.54) | OPRM1OPRK1F2NTSR2NTSR1 | |
| SCHEMBL30392594 | 0.86 | F2 (0.54) | OPRM1OPRK1F2NTSR2NTSR1 | |
| SCHEMBL29607267 | 0.86 | F2 (0.54) | OPRM1OPRK1F2NTSR2NTSR1 | |
| SCHEMBL29887046 | 0.86 | F2 (0.47) | OPRM1OPRK1F2NTSR2NTSR1 | |
| SCHEMBL10595911 | 0.85 | EPHA2 (0.55) | OPRM1OPRK1APLNRCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7754858-B2 | Antibodies to tumor necrosis factor receptor associated factor polypeptides | GENENTECH, INC. (US) | 2010-07-13 | — | — | US | disclosed |
| EP-2011873-A2 | Tumor necrosis factor receptor-associated factors | Genentech, Inc. (US) | 2009-01-07 | — | — | EP | disclosed |
| EP-0760851-B1 | TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS | GENENTECH INC (US) | 2008-07-09 | — | — | EP | disclosed |
| US-20070243202-A1 | TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS | GENENTECH, INC. (US) | 2007-10-18 | — | — | US | disclosed |
| US-7244836-B2 | Tumor necrosis factor receptor-associated factors | GENENTECH, INC. (US) | 2007-07-17 | — | — | US | disclosed |
| US-20030120043-A1 | Tumor necrosis factor receptor-associated factors | GENENTECH, INC. | 2003-06-26 | — | — | US | disclosed |
| US-5869612-A | AMINO ACID SEQUENCE OF ISOLATED PROTEIN INVOLVED IN POST-RECEPTOR SIGNAL TRANSDUCTION; TREATMENT OF RHEUMATOID ARTHRITIS AND SEPTIC SHOCK | GENETECH, INC. (US) | 1999-02-09 | — | — | US | disclosed |
| US-5741667-A | NUCLEIC ACID WHICH CODES FOR A RECEPTOR PROTEIN BY ACTING AS A VECTOR FOR GENETICALLY ENGINEERED CELLS | GENENTECH, INC. (US) | 1998-04-21 | — | — | US | disclosed |
| US-5708142-A | AMINO ACID SEQUENCE | GENENTECH, INC. (US) | 1998-01-13 | — | — | US | disclosed |
| US-5670319-A | Assay for tumor necrosis factor receptor-associated factors | GENENTECH, INC. (US) | 1997-09-23 | — | — | US | disclosed |